Vantive’s Transformative Impact on Renal Care
Vantive has the unique distinction of being an established company with a rich legacy and a brand-new firm that’s fresh and agile. Vantive CEO Chris Toth discusses the company's renal care focus, its Baxter separation, and medtech leadership insights in this Let's Talk Medtech episode.
Here is why we are talking about Vantive, a company spunoff from Baxter and taken over by a private deep pockets investor, Carlyle Group ..
What Vantive is referring to is Spectral Medical's Inc. (EDT.TO) TIGRIS Phase III data which will be released in about 6 weeks or so.. If you own shares in Spectral, Keep your fingers crossed.. Since we are talking about Biotech, risk tends to be high etc. so Spectral Medical Inc. as an investment is not exactly for, as they say, orphans and widows..
Follwoing is an Extract from the article related to Spectral..
""...Over the next 12 months, extending into 2026, you'll see more of these tools rolling out and scaling accordingly. You'll also see more capabilities and launches in the acute care setting. We just completed, in partnership with Spectral, the accrual phase for a trial of PMX septic shock therapy. All that data is being processed for FDA filing and subsequent steps.
As we move into 2026, likely the second half, we'll see that therapy become available. This therapy is particularly exciting because sepsis or septic shock accounts for one in five deaths in the United States, with limited treatment options available. This particular therapy showed in a previous larger clinical trial that for a subset of cases within a certain infection range—identified through an endotoxin assay—we could substantially reduce the relative risk of mortality. That's what truly matters: how we extend life and expand possibilities.
This therapy represents another component of our investments. We're putting significant resources behind it to ensure that as we progress from filing to launch, we not only have compelling clinical data to present but also the right infrastructure and supply chain support to deliver for patients..."
mddionline.com |
